LGD-2226

Other names: LGD2226, 6-(bis-(2,2,2-trifluoroethyl)amino)-4-trifluoromethyl-1H-quinolin-2-one

Classifications: 6000

Reasons for prohibition: - WADA S1: Anabolic Agents (source) - Unapproved Drug - FDA Statement

References: - {'title': 'NIH NCATS Inxight Drugs entry: LGD-2226', 'url': 'https://drugs.ncats.io/drug/RI376RM5MT'} - {'title': 'FDA warns against using SARMs in body-building products', 'url': 'https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products'}

Reason: WADA S1: Anabolic AgentsUnapproved drugFDA statement: SARMs

Searchable name: lgd-2226

GUID: f8ac0603-0b83-4746-aed2-68ef75538f22

Added: 2026-01-01T00:09:47.312568+00:00

Updated: {"_seconds": 1709838302, "_nanoseconds": 554000000}